Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
Date:1/20/2010

PLEASANTON, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has received FDA approval of its PMA (Pre-Market Approval) supplement, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) for Destination Therapy (DT).  

With this approval, the HeartMate II can be used to provide long-term cardiac support for patients suffering from advanced-stage heart failure who are not eligible for transplantation. Thoratec said it will begin the rollout of the device for the DT indication immediately and has sufficient inventory to address the expected increase in demand. The device was approved for Bridge-to-Transplantation (BTT) in the U.S. under the original PMA in April 2008.

The approval allows the HeartMate II to be used in patients with New York Heart Association (NYHA) Class IIIB or IV end-stage left ventricular failure who have received optimal medical therapy for at least 45 of the last 60 days, and who are not candidates for cardiac transplantation. The PMA approval was based on a filing submitted in April 2009 that included two-year data on a pivotal study cohort of 200 randomized patients enrolled at 38 centers. Patients in the HeartMate II DT trial were randomized to the HeartMate II or the HeartMate® XVE—the only other device approved for DT—on a 2:1 basis, respectively. Patients in the pivotal cohort ranged in age from 26-81 years old, with a median age of 64 years. Also included in the primary analysis were data on 24 small BSA (body surface area) patients who because of their bod
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Presentation at Canaccord Adams Conference to be Webcast
5. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
6. Thoratec Presentation at Piper Jaffray Conference to be Webcast
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Decision Resources Group finds ... Memphis health system and hospital ... integration, with rivals Methodist Le Bonheur Healthcare and Baptist ... to coordinate patient care. In addition, a national contract ... most health plan enrollment in the Memphis ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... Aug. 27, 2014 By now, if you haven,t ... living on this planet. The awareness campaign has brought this ... helped to raise over $88.5 Million (and counting) for ALS. ... some companies are starting to as well. One ... Florida , who actually works with ALS sufferers and ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... 31, 2011 MultiCell Technologies, Inc. (OTC Bulletin Board: ... U.S. patent 7,935,528 by the United States Patent and Trademark ... liver stem cells to treat liver disease.  Under the terms ... is the worldwide exclusive licensee of U.S. patent 7,935,528.   ...
... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... Mr. Kenneth Lee as a director to the Board of ... Xianping Wang who resigned from the Board due to personal ... SAIF Partners, a leading growth capital fund focused on China ...
Cached Medicine Technology:MultiCell Technologies is Granted Stem Cell Patent 2MultiCell Technologies is Granted Stem Cell Patent 3Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:8/27/2014)... (PRWEB) August 27, 2014 The ... the recipients of the 2014-2016 Basic Research Fellowships and ... career scientists, the ABTA is seeding the field with ... change our understanding of the causes, effects, diagnosis and ... by a scientific committee based on the potential to ...
(Date:8/27/2014)... Scottsdale, AZ (PRWEB) August 27, 2014 ... provider of in-home care for seniors, is proud to ... Webinar Series. The upcoming webinar will feature Dr. Suzanne ... at Lenox Hill Hospital in New York City, National ... and author. The webinar will cover the issues surrounding ...
(Date:8/27/2014)... drug designed to help regulate the blood,s iron supply shows ... according to results from the first human study ... , the Journal of the American Society of ... red blood cells are in short supply or do not ... not get enough oxygen, since there are fewer red blood ...
(Date:8/27/2014)... According to a new market ... Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, ... - Global Industry Analysis, Size, Share, Growth, Trends ... technologies market was valued at USD 4,698 million ... market worth USD 10,611 million in 2020 at ...
(Date:8/27/2014)... trial participation in the largest ongoing observational study of ... representative of the larger patient base, according to a ... Udell. The study authors call into question the general ... suggest the use of broader enrollment criteria and existing ... that clinical trials can be tremendously expensive and a ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Drug represents first potential treatment for common anemia 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2
... say the autism rate in the U.S. is now 1 in ... country know those statistics are inaccurate. , Misdiagnosis is the hottest ... misdiagnosed with autism , a label parents are often pushed ... October 9-11, in 90+ cities around the world, parents will gather ...
... 2009 Golden Apple Awards , CHICAGO, Oct. ... state and local dental societies across the nation with the ... in its 21st year, recognizes outstanding achievement in dental society ... Apple Awards will be presented through the end of the ...
... at Fred Hutchinson Cancer Research Center, Group Health ... of Public Health and Pharmacy have been selected ... million in federal stimulus funding for comparative-effectiveness research ... national hub for conducting such research, which aims ...
... National Institutes of Health announced today a second phase ... funds for 19 research consortia. The Rare Diseases Clinical ... will be awarded a total of just over $117 ... with the new funding will explore the natural history, ...
... widely used for applications that include inventory management, ... luggage security. More recently, these systems have found ... equipment assets and staff members. However, there ... which manufacturers of RFID equipment or medical devices ...
... College of Preventive Medicine (ACPM) supports the recommendations of ... care providers should screen all adults for depression, and ... systems in place to ensure the accurate diagnosis and ... opportunities to identify depression are in the clinics of ...
Cached Medicine News:Health News:Autism Stats Exaggerated: Parents Pushing Back This Weekend 2Health News:ADA Honors State and Local Dental Societies for Their Outreach Programs 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 2Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 3Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 4Health News:$16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 2Health News:NIH announces expansion of Rare Diseases Clinical Research Network 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 4Health News:NIH announces expansion of Rare Diseases Clinical Research Network 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 6Health News:NIH announces expansion of Rare Diseases Clinical Research Network 7Health News:NIH announces expansion of Rare Diseases Clinical Research Network 8Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 2Health News:GTRI is developing protocols for testing effects of RFID systems on medical devices 3
... wide Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 15 x 7 cm ... two casting gates, and two 1.5 ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
Medicine Products: